Clinicians warn of the dangers of equating COVID-19 with high altitude pulmonary edema

April 30, 2020

April 29, 2020 - Early reports of COVID-19 symptoms and the compelling need to quickly identify treatment options and curb the growing number of critically ill patients have led to erroneous and potentially dangerous comparisons between COVID-19 and other respiratory diseases like high altitude pulmonary edema, or HAPE.

In "Annals of the American Thoracic Society.

There are some similarities between COVID-19 and HAPE as there are similarities between COVID-19 and other respiratory illnesses that cause respiratory failure: very low oxygen levels in the blood, significant difficulty breathing, the degree to which there is stiffness in the lungs, and abnormal findings on chest CT scans. However, there are fundamental differences between COVID-19 and HAPE.

"HAPE develops when people ascend to high altitude. The low oxygen levels in the atmosphere cause low oxygen levels in the air sacs of the lungs," said Andrew Luks, MD, professor of medicine in the Division of Pulmonary, Critical Care and Sleep Medicine at Harborview Medical Center and the University of Washington. "In all people, this leads the blood vessels in the lungs to constrict and raises the blood pressure in the lungs (pulmonary artery pressure). In people who develop HAPE, this response is excessive.

There is far too much vasoconstriction and far too great a rise in pulmonary artery pressure, all of which lead fluid to leak out of the blood vessels into the lung tissue, but this occurs with no inflammation."

"In lung injury due to COVID-19, the virus attacks the cells that make up the air sacs of the lungs. This leads to a big inflammatory response that damages the air sacs (alveoli), leading fluid to leak out of the blood vessels even under much lower pressures, causes the alveoli to collapse, interferes with gas exchange and makes the lungs stiffer and harder to expand than normal. "

These fundamental differences necessitate different treatment approaches. While treatment with oxygen can resolve HAPE symptoms, oxygen alone is ineffective for the lung injury associated with COVID-19. Nifedpine and acetazolamide, two medications used to treat altitude sickness, can have dangerous consequences in COVID-19 patients.

"If given to a patient with lung injury due to COVID-19, it [nifedpine] has the potential to actually worsen oxygen levels in the blood and to lower systemic or whole body blood pressure," said Dr. Luks.

Treating with acetazolamide can cause a host of problems, among them "fatigue of the diaphragm, causing the blood to become more acidic, and at high enough concentrations in the blood, impairing the transport and elimination of carbon dioxide, all of which will make patients even more short of breath."

COVID-19 has affected how the medical community shares information and what the community is learning about the disease can change quickly. Clinicians and families are looking for data to help care for patients. Dr. Luks and his co-authors warn that without careful scrutiny, misinformation can quickly spread. Now more than ever, it is critical that clinicians rely on the data accumulated over time and scientific evidence related to treating acute lung injury.
About the

The AnnalsATS is a peer-reviewed journal published by the American Thoracic Society. The Journal delivers up-to-date and authoritative coverage of adult and pediatric pulmonary and respiratory sleep medicine and adult critical care. The scope of the Journal encompasses content that is applicable to clinical practice, the formative and continuing education of clinical specialists and the advancement of public health. The journal's impact factor is 4.026.

Editor: Colin Cooke, MD, MS, associate professor in the department of internal medicine at the University of Michigan.

About the American Thoracic Society Founded in 1905, the American Thoracic Society is the world's leading medical association dedicated to advancing pulmonary, critical care and sleep medicine. The Society's 15,000 members prevent and fight respiratory disease around the globe through research, education, patient care and advocacy. The ATS publishes four journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology, the Annals of the American Thoracic Society and ATS Scholar.

American Thoracic Society

Related Led Articles from Brightsurf:

Impurities enhance polymer LED efficiencies
New research published in EPJ B reveals that the higher-than-expected efficiency of PLEDs can be reached through interactions between triplet excitons, and impurities embedded in their polymer layers.

UCLA-led team of scientists discovers why we need sleep
Why is sleep so vital to our health? A UCLA-led team of scientists has answered this question and shown for the first time that a dramatic change in the purpose of sleep occurs at the age of about 2-and-a-half.

Study pinpoints process that might have led to first organic molecules
New research led by the American Museum of Natural History and funded by NASA identifies a process that might have been key in producing the first organic molecules on Earth about 4 billion years ago, before the origin of life.

Layer of nanoparticles could improve LED performance and lifetime
Adding a layer of nanoparticles to LED designs could help them produce more light for the same energy, and also increase their lifetime.

Mini-LED, Micro-LED and OLED displays: Present status and future perspectives
''Mini-LED, Micro-LED or OLED displays: who wins?'' is a heated debatable question.

Indigenous-led health care partnerships flourishing in Canada
Innovative, Indigenous-led health care partnerships and cultural healing practices have shown improved health outcomes and access to care, and have become important features of the medical landscape in Canada, according to a new analysis in CMAJ (Canadian Medical Association Journal).

A way to look younger is right under your nose, UCLA-led study finds
Rhinoplasty, or cosmetic nose surgery, may make a woman look up to three years younger, according to a new study led by researchers at UCLA that used a type of artificial intelligence known as machine learning.

LED lighting in greenhouses helps but standards are needed
While LED lighting can enhance plant growth in greenhouses, standards are needed to determine the optimal intensity and colors of light, according to Rutgers research that could help improve the energy efficiency of horticultural lighting products.

Pharmacist-led interventions may help prevent cardiovascular disease
With their expertise in the safe and effective use of medications, pharmacists can help in the management of chronic diseases.

HKU-led study on language speed and efficiency
Are some languages more efficient than others? In a recent study led by the University of Hong Kong (HKU) titled 'Different languages, similar encoding efficiency: comparable information rates across the human communicative niche', an international and interdisciplinary team comprising scientists at the Laboratoire Dynamique Du Langage (France), Ajou University (South Korea) and HKU analyzed 17 languages and found that all languages convey information at similar rates, regardless of whether they are spoken faster or slower.

Read More: Led News and Led Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to